Overview of NICE’s Elranatamab Managed Ac...

By João L. Carapinha

October 29, 2024

NICE recently recommended Elranatamab as an option for treating relapsed and refractory multiple myeloma in adults with a man...
Ozempic Shows Promise in Reducing Alzheimer’s Risk
Neoadjuvant Chemotherapy: Transforming Treatment for Advanced Ovarian Cancer
CTO-PCI Technology for Heart Health in Egypt
NICE Rejects Donanemab for NHS Use Due to Cost Concerns
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs
Congo Launches Mpox Vaccination Campaign to Address Outbreak
Saudi Healthcare Reform: Vision 2030 and Beyond
Transforming Value-Based Oncology Care: A Multifaceted Approach
Bupa Launches Whole Genome Sequencing Pilot in UK
HARMONi-2 Trial Results Transforming NSCLC
KEYTRUDA Head Neck Cancer Phase 3 Trial
UNAIDS Urges Greater Access for Gilead’s Lenacapavir